Showing results (441-450 of 1,480) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|August 26, 2010
A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorderFarhad Soltani, Mehdi Sayyah, Fariba Feizy, et al.Human Psychopharmacology|September 23, 2010
Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depressionYutaro Suzuki, Nobuto Tsuneyama, Naoki Fukui, et al.Human Psychopharmacology|September 23, 2010
Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trialAli-Reza Zarinara, Mohammad-Reza Mohammadi, Nazanin Hazrati, et al.Human Psychopharmacology|April 8, 2010
A psychoneuroimmunological review on cytokines involved in antidepressant treatment responseDebbie G A Janssen, Riccardo N Caniato, Joris C Verster, et al.Human Psychopharmacology|April 8, 2010
Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcomeKeith Lloyd, Muhammud A Latif, Steve Simpson, et al.Human Psychopharmacology|April 8, 2010
Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patientsArun K Tiwari, Clement C Zai, Herbert Y Meltzer, et al.Human Psychopharmacology|April 8, 2010
The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteersMasahiro Takahashi, Kunihiro Iwamoto, Yukiko Kawamura, et al.Human Psychopharmacology|July 29, 2009
Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonistDanijela Piskulić, James S Olver, Paul Maruff, et al.Human Psychopharmacology|August 22, 2009
Does the presence of a pharmacological substance alter the placebo effect?--results of two experimental studies using the placebo-caffeine paradigmHarald Walach, Rainer SchneiderPageof 148